How to store highly sensitive drugs? The benefit of functional coatings.
This article, written in collaboration with SCHOTT Pharmaceuticals packaging, highlights the benefit of the use of Type I Plus® SCHOTT vials to resolve stability issues of sensitive drugs.
BOS Basel 2020 - Legacy is Gold Sponsor
Legacy Pharmaceuticals Switzerland GmbH Confirms Gold Sponsor Package in partnership with SCHOTT Pharmaceutical Systems at BOS Basel 2020.
Meet us @ CPhI Frankfurt 2019
From the 5th to the 7th of Nov. 2019 the annual CPhI Worldwide will take place at the Messe in Frankfurt. Also Legacy will participate as an exhibitor.
Legacy ramps up preparations for Russian track-and-trace regulations
Swiss pharma supplier has installed and certified new Bosch serialisation and aggregation equipment on three packaging lines...
Legacy Pharmaceuticals announces long-term lyophilisation strategy!
On the 7th of May, Legacy Pharmaceuticals will be present as an exhibitor during the Swiss Biotech Day.
Legacy improves AntiViral drug with SCHOTT Type I plus vials
Legacy Pharmaceuticals and SCHOTT are now offering a solution to future customers with a need to provide better stability, particularly for highly sensitive formulations.
Meet us @ the SWISS BIOTECH DAY 2019
On the 7th of May, Legacy Pharmaceuticals will be present as an exhibitor during the Swiss Biotech Day
How CMO Legacy Pharma found Developments and the middle groundfuture of pharmaceutical packaging
With the global primary packaging market in the pharmaceutical sector expected to experience remarkable growth during the next few years, Dr Kevin Robinson asked a number of industry experts to comment on the hurdles, drivers and emerging trends that are influencing how drugs are formulated, packaged and delivered.